Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL-6 and Osteoprotegerin
- 1 February 2006
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (2) , 228-236
- https://doi.org/10.1359/jbmr.051021
Abstract
We showed that human osteoprogenitor cells produced adenosine and expressed ecto-5′-nucleotidase and all four adenosine receptor subtypes. Adenosine stimulated IL-6 but inhibited osteoprotegerin secretion, suggesting that adenosine is a newly described regulator of progenitor cell function. Introduction: Maintaining skeletal homeostasis relies on there being a balance between bone formation and resorption; an imbalance between these processes can lead to diseases such as osteoporosis and rheumatoid arthritis. Recent reports showed that locally produced ATP, acting through P2 receptors, has pronounced effects on bone formation. However, ATP can be enzymatically cleaved to adenosine that has little or no activity at P2 receptors but mediates its action through the P1 family of receptors. We studied whether adenosine may also have an important role in controlling bone cell differentiation and function. Materials and Methods: Extracellular adenosine levels were analyzed by high-performance liquid chromatography in HCC1 and bone marrow stromal (BMS) cells. Ecto-5′-nucleotidase (CD73) expression and activity was determined by RT-PCR, immunocytochemistry, and the cleavage of etheno-AMP to ethenoadenosine. Adenosine receptor expression and activity were determined by RT-PCR and cAMP measurements. The effects of adenosine receptor agonists on IL-6, osteoprotegerin (OPG), and RANKL expression were determined by ELISA and QRT-PCR. Results: HCC1 and BMS cells produce adenosine and express CD73 and all four adenosine receptor subtypes. The A2b receptor was shown to be functionally dominant in HCC1 cells, as determined by cAMP production and in its stimulation of IL-6 secretion. Adenosine receptor agonism also inhibited OPG secretion and OPG but not RANKL mRNA expression. Conclusions: Our findings show that HCC1 and primary BMS cells produce adenosine, express CD73 and all four adenosine receptor subtypes. In HCC1 cells, adenosine has a potent stimulatory action on IL-6 secretion but an inhibitory action on OPG expression. These data show for the first time that adenosine may be an important regulator of progenitor cell differentiation and hence an important local contributor to the regulation of bone formation and resorption.Keywords
This publication has 38 references indexed in Scilit:
- Characterization of Multipotential Mesenchymal Progenitor Cells Derived from Human Trabecular BoneThe International Journal of Cell Cloning, 2003
- Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammationThe FASEB Journal, 2003
- Adenosine‐induced IL‐6 expression in pituitary folliculostellate cells is mediated via A2b adenosine receptors coupled to PKC and p38 MAPKBritish Journal of Pharmacology, 2003
- Release and interconversion of P2 receptor agonists by human osteoblast‐like cellsThe FASEB Journal, 2003
- Regulation of bone resorption and formation by purines and pyrimidinesTrends in Pharmacological Sciences, 2003
- Adenosine triphosphate stimulates human osteoclast activity via upregulation of osteoblast-expressed receptor activator of nuclear factor-κB ligandBone, 2002
- Shedding of the Interleukin-6 (IL-6) Receptor (gp80) Determines the Ability of IL-6 to Induce gp130 Phosphorylation in Human OsteoblastsPublished by Elsevier ,2002
- Ecto‐alkaline phosphatase in NG108‐15 cells : a key enzyme mediating P1 antagonist‐sensitive ATP responseBritish Journal of Pharmacology, 2000
- Osteoprotegerin mRNA Is Increased by Interleukin-1α in the Human Osteosarcoma Cell Line MG-63 and in Human Osteoblast-Like CellsBiochemical and Biophysical Research Communications, 1998
- Adenosine A2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma CellsJournal of Neurochemistry, 1996